Assessment of benefits of nasal and alveolar molding before surgical repair of lip in infants with cleft lip and palate
Not Applicable
Completed
- Conditions
- Health Condition 1: Q370- Cleft hard palate with bilateral cleft lipHealth Condition 2: Q371- Cleft hard palate with unilateralcleft lip
- Registration Number
- CTRI/2019/09/021422
- Lead Sponsor
- Department of Health Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
infants born with unilateral or bilateral cleft lip and palate
Exclusion Criteria
syndromic cleft lip and palate
systemic illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are involved in nasoalveolar molding (NAM) for Q370/Q371 cleft lip and palate correction?
How does pre-surgical NAM compare to traditional surgical approaches in improving Q370/Q371 cleft lip and palate outcomes?
Are there genetic biomarkers associated with response to NAM in infants with Q370/Q371 cleft lip and palate?
What adverse events are reported with NAM in Q370/Q371 cleft lip and palate infants, and how are they managed?
How does NAM integrate with orthodontic or multidisciplinary therapies for Q370/Q371 cleft lip and palate management?